Maria Abraxas, is a
Home Health based in Rockville, Maryland. Maria Abraxas is licensed to practice in Maryland (license number 07287) and her current practice location is
6030 California Cir Apt 413, Rockville, Maryland. She can be reached at her office (for appointments etc.) via phone at
(240) 476-8543.
NPI number for Maria Abraxas is 1548717051 and her current mailing address is 6030 California Circle, Apt 413, Rockville, Maryland. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1548717051.
Healthcare Provider's Profile
Full Name | Maria Abraxas |
---|
Gender | Female |
---|
Speciality | Home Health |
---|
Location | 6030 California Cir Apt 413, Rockville, Maryland |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1548717051
- Provider Enumeration Date: 09/01/2016
- Last Update Date: 07/21/2022
Medical Identifiers
Medical identifiers for Maria Abraxas such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1548717051 | NPI | - | NPPES |
1548717051 | Medicaid | MD | |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
225X00000X | Occupational Therapist | (* (Not Available)) | Secondary |
251E00000X | Home Health | 07287 (Maryland) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Maria Abraxas is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Maria Abraxas, 6030 California Circle, Apt 413, Rockville, MD 20852 Ph: (240) 476-8543 | Maria Abraxas, 6030 California Cir Apt 413, Rockville, MD 20852-4842 Ph: (240) 476-8543 |
Reviews and Comments